In five years since AlphaFold's debut, it has transformed basic biochemical research. But its long-term effect on drug ...
5don MSN
Scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases
More than 300 people across academia and industry spilled into an auditorium to attend a BoltzGen seminar on Thursday, Oct.
Proteins are the workhorses that keep our cells running, and there are many thousands of types of proteins in our cells, each ...
The team behind DeepMind’s protein structure prediction software AlphaFold announced Oct. 31 that it is expanding its model beyond proteins. Ligands, nucleic acids, and post-translational ...
Fully open source model accurately predicts the 3D structures of proteins and biomolecules in silico, and serves as a foundational model for next generation of cutting-edge Protein AI tools The ...
Researchers at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University observe and model how the enzyme ADAR1 interacts with double-stranded RNA, which may be useful for future cancer ...
As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new ...
Gero, a biotechnology company developing novel therapeutics for aging and chronic diseases, has released ProtoBind-Diff, a novel masked diffusion language model that generates drug-like molecules for ...
Professor Jonathan Wittenberg used this model of sperm whale myoglobin structure as a teaching tool at the Albert Einstein College of Medicine at Yeshiva University in the Bronx. It was used beginning ...
New imaging reveals cancer-linked ADAR1 enzyme structure, potentially enabling targeted therapies by combining HS-AFM and 3D modeling techniques. (Nanowerk News) An enzyme type noted in several ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback